Erschienen in:
19.12.2016 | CORR Insights
CORR Insights®: Can We Estimate Short- and Intermediate-term Survival in Patients Undergoing Surgery for Metastatic Bone Disease?
verfasst von:
Michelle Ghert, MD, FRCSC
Erschienen in:
Clinical Orthopaedics and Related Research®
|
Ausgabe 4/2017
Einloggen, um Zugang zu erhalten
Excerpt
The development of novel targeted drugs, a renewed focus in immunotherapy, and improved symptom management have extended the life expectancy for a number of cancers [
14]. Advancements in the systemic management of metastatic carcinoma can transform cancer into a chronic condition for some patients [
1]. However, as life expectancies increase, we may see more patients with carcinomas who develop skeletal metastases, pathologic fractures, and spinal compression [
4,
5,
15]. …